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Gene ofﬁ cial symbol Gene name Location Possible pathways / pathological biological processes
MenDeLIAn Genes
APP Amyloid β (A4) precursor protein 21q21.3 Damage response?/Amyloid cascade
PSEN1 Presenilin 1 14q24.3 Regulation of APP processing (amyloid cascade); cleavage of APP, the Notch receptor, 
and other transmembrane proteins
PSEN2 Presenilin 2 1q31-q42 Regulation of APP processing (amyloid cascade); cleavage of APP, the Notch receptor, 
and other transmembrane proteins
RIsK Genes
APOE Apolipoprotein E 19q13.2 Cholesterol/lipid metabolism
TREM2 Triggering receptor expressed on myeloid 
cells 2
6p21.1 Immune response; chronic infl ammation 
RIsK LOcI
CLU Clusterin 8p21-p12 Immune and complement systems/infl ammatory response; cholesterol/lipid metabolism
PICALM Phosphatidylinositol-binding clathrin as-
sembly protein
11q14 Clathrin-mediated endocytosis 
CR1 Complement component (3b/4b) receptor 
1 (Knops blood group)
1q32 Immune and complement systems/infl ammatory response
BIN1 Bridging integrator 1 2q14 Synaptic vesicle endocytosis 
MS4A6A Membrane-spanning 4 domains, subfam-
ily A, member 6A
11q12.1 Immune and complement systems/infl ammatory response
MS4A4E Membrane-spanning 4 domains, subfam-
ily A, member 4E
11q12.2 Immune and complement systems/infl ammatory response
CD33 CD33 molecule 19q13.3 Immune and complement systems/infl ammatory response
ABCA7 ATP-binding cassette, subfamily A 
(ABC1), member 7
19p13.3 Cholesterol/lipid metabolism; Immune and complement systems/infl ammatory 
response
CD2AP CD2-associated protein 6p12 Receptor endocytosis and cytokinesis
EPHA1 EPH receptor A1 7q34 Immune and complement systems/infl ammatory response
HLA-DRB5 and DRB1 Major histocompatibility complex, class II, 
DR beta 5 and DR beta 1
6p21.3 Immune response and infl ammation
SORL1 Sortilin-related receptor, L(DLR class) A 
repeats containing
11q23.2-q24.2 Endocytosis and cargo sorting (traffi cking and metabolism of APP), lipid transport
PTK2B Protein tyrosine kinase 2 beta 8p21.1 Hippocampal synaptic function; cell migration 
SLC24A4 Solute carrier family 24 (sodium/potas-
sium/calcium exchanger), member 4
14q32.12 Possible cardiovascular link
ZCWPW1 Zinc fi nger, CW type with PWWP domain 1 7q22.1 Epigenetic regulation
CELF1 CUGBP, Elav-like family member 1 11p11 Cytoskeletal function and axonal transport
FERMT2 Fermitin family member 2 14q22.1 Angiogenesis, Tau pathology
CASS4 Cas scaffolding protein family member 4 20q13.31 APP and Tau pathology; Cytoskeletal function and axonal transport
INPP5D Inositol polyphosphate-5-phosphatase, 
145kDa
2q37.1 Immune response and infl ammation; APP metabolism
MEF2C Myocyte enhancer factor 2C 5q14.3 Immune response and infl ammation; Hippocampal synaptic function
NME8 NME/NM23 family member 8 7p14.1 Cytoskeletal function and axonal transport
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GENETIC LANDSCAPE OF ALZHEIMER’S DISEASE
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Genetic Landscape of Alzheimer’s Disease
Different types of genetic technologies and approaches allow for the study and identification of different types of genetic variability in a disease. Here represented are 
the genes and genetic loci independently replicated as being associated with the development of Alzheimer’s disease (AD). Genetic linkage analyses (blue area) of famil-
ial cases have led to the identification of causative mutations in three genes: APP, PSEN1, and PSEN2, as well the identification of a high-risk factor: the E4 allele of APOE. 
More recently, the development of whole-genome genotyping platforms has allowed for the study of the involvement of common variants with low risk in the disease (orange 
area). This has led to the identification of 21 new genetic loci by several independent genome-wide association studies (GWAS): CLU, PICALM, CR1, BIN1, CD33, ABCA7, 
MS4A6A and MS4A4E (represented here as MS4A), CD2AP, EPHA1, HLA-DRB5/DRB1, SORL1, PTK2B, SLC24A4, ZCWPW1, CELF1, FERMT2, CASS4, INPP5D, MEF2C, and 
NME8. Because of the way that these studies are designed, they only identify genetic regions associated with disease and not specific genes or variants. For this reason, if 
the significant single-nucleotide polymorphisms (SNPs) are intergenic or if the region contains more than one gene, the locus usually gets its name from the gene closest to 
the significant hit. Very few of these significant hits have a clear functional role in the disease, and because of this, follow-up work is currently underway to determine exactly 
which genetic variants are important for the disease and how they are exerting their effect.
The integration of recently developed sequencing technologies (whole-exome and whole-genome sequencing, green area) with genotyping data has allowed the identifica-
tion of the first rare variant with intermediate risk for AD in TREM2. These findings have clearly pointed to the involvement of several biological pathways in the etiopathogen-
esis of AD, as the implicated genes and loci seem to not be independent from each other; instead, they seem to cluster in several biological pathways (represented by different 
colors in the table).
The finding of mutations in APP (and at a later stage the recognition that presenilins function at the γ-secretase complex level) led to the establishment of the amyloid cas-
cade hypothesis. This suggests that the dysregulation of APP is the initiating event in AD pathogenesis, subsequently leading to the aggregation of Aβ. Formation of neuritic 
plaques would initiate further pathological events, including the development of neurofibrillary tangles and disruption of synaptic connections, which would lead to a reduction 
in neurotransmitters, death of tangle-bearing neurons, and eventually dementia. The more recent pathway analyses of GWAS data have implicated other pathways as primary 
etiological events in the disease, with clear, significant overrepresentation of association signals in pathways related to cholesterol metabolism and the immune response.
Pleomorphic Risk, Exemplified by APP
This panel illustrates that, at the same locus, several disease-related genetic mechanisms may coexist, each influencing disease through different biological effects on a 
single gene. In this particular model, expression of a gene is positively correlated with risk shown by duplication mutations of the APP locus, which are known to cause AD. 
Several different coding mutations (all located in exons 16 and 17 of the APP gene, which encode the amyloid β region of the protein) have been identified as the cause of 
disease in mainly early onset familial cases. More recently, a protective mutation (p.A673T) has been described in Scandinavian population.
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